购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Dehydrogenase
    (1)
  • VEGFR
    (1)
  • Others
    (4)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 6-8周
    (2)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "myelosuppression"的结果
筛选
搜索结果
TargetMol产品目录中 "

myelosuppression

"的结果
  • 抑制剂&激动剂
    5
    TargetMol | Inhibitors_Agonists
  • 化合物库
    1
    TargetMol | Compound_Libraries
  • 天然产物
    1
    TargetMol | Natural_Products
  • PTC299
    Emvododstat, (4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate
    T125741256565-36-2
    PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) 是一种口服活性的 VEGFA mRNA 翻译抑制剂,可选择性地抑制转录后水平的 VEGF 蛋白合成。它还是二氢乳酸脱氢酶 (DHODH) 的有效抑制剂,可研究血液系统恶性肿瘤。
    • ¥ 898
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • Panaxatriol
    人参三醇, Panaxtriol
    T280432791-84-7
    Panaxatriol (Panaxtriol) 是一种能够减轻由于辐射损伤造成的骨髓抑制的天然产物。
    • ¥ 108
    In stock
    规格
    数量
  • Contezolid acefosamil sodium
    T364411807365-35-0
    Contezolid acefosamil sodium (MRX-4) is a novel orally active oxazolidinone antibiotic under investigation for the treatment of complicated skin and soft tissue infections (cSSTI) caused by drug-resistant Gram-positive bacteria. It possesses strong efficacy against these pathogens while significantly minimizing the risks of myelosuppression and monoamine oxidase inhibition (MAOI) [1][2].
    • ¥ 7419
    待询
    规格
    数量
  • Mitobronitol
    T60731488-41-5
    Mitobronitol (Myelobromol; DBM) 是甘露醇的溴化类似物。Mitobronitol 是被归类为烷化剂的抗癌剂。Mitobronitol 具有骨髓抑制作用,可显著降低加速慢性粒细胞白血病异体骨髓移植的几种并发症的风险。
    • ¥ 10600
    6-8周
    规格
    数量
  • PC-046
    T712521202401-59-9
    PC-046 is a potent tubulin-binding agent, which was originally identified for development based on selective activity in deleted in pancreas cancer locus 4 (DPC4 SMAD4) deficient tumors. PC-046 has growth inhibitory activity in a variety of tumor types in vitro, and efficacy in SCID mice was shown in human tumor xenografts of MV-4-11 acute myeloid leukemia, MM.1S multiple myeloma, and DU-145 prostate cancer. Pharmacokinetic studies demonstrated relatively high oral bioavailability (71 %) with distribution to both plasma and bone marrow. No myelosuppression was seen in non-tumor bearing SCID mice given a single dose just under the acute lethal dose. The COMPARE algorithm in the NCI-60 cell line panel demonstrated that PC-046 closely correlated to other known tubulin destabilizing agents (correlation coefficients ≈0.7 for vincristine and vinblastine). Mechanism of action studies showed cell cycle arrest in metaphase and inhibition of tubulin polymerization. Overall, these studi......
    • ¥ 10600
    6-8周
    规格
    数量